Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
PERSONAL FINANCE
Stay Away From These Closed-End Funds
By Kevin Baker
Sep 18, 2008 1:30 AM EDT
PRESS RELEASES
IIROC Trading Resumption - GRF
By PR Newswire
Dec 23, 2020 12:16 PM EST
PRESS RELEASES
IIROC Trading Halt - GRF
By PR Newswire
Dec 23, 2020 8:56 AM EST
PRESS RELEASES
Eagle Capital Growth Fund Opts Into Maryland Control Share Acquisition Act
By Business Wire
Dec 7, 2020 5:20 PM EST
PRESS RELEASES
Eagle Capital Growth Fund Declares Year-End Distribution Of $0.55 Per Share
By Business Wire
Nov 23, 2020 4:32 PM EST
PRESS RELEASES
The Dow Jones Sustainability Index Recognizes Grifols As One Of The World's Most Sustainable Companies
By PR Newswire
Nov 16, 2020 9:14 AM EST
PRESS RELEASES
Grifols Partners With TRC Healthcare To Streamline Intravenous Compounding Education
By PR Newswire
Nov 12, 2020 9:00 AM EST
PRESS RELEASES
Grifols' Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial In Patients With COVID-19
By PR Newswire
Oct 9, 2020 6:23 AM EDT
PRESS RELEASES
Grifols Closes The Acquisition Of Green Cross Fractionation Plant In Canada And 11 Plasma Centers In The U.S.
By PR Newswire
Oct 1, 2020 12:13 PM EDT
PRESS RELEASES
Grifols To Acquire Alkahest To Enhance Discovery Research And Development To Identify Innovative Therapies For Age-related Diseases Based Upon An Understanding Of The Human Plasma Proteome
By PR Newswire
Sep 7, 2020 2:50 AM EDT
PRESS RELEASES
ICU Medical Broadens Its Non-PVC/Non-DEHP IV Solutions Portfolio By Entering Long-Term U.S. Distribution Agreement With Grifols For Certain Core IV Solution Products
By PR Newswire
Aug 10, 2020 4:00 PM EDT
PRESS RELEASES
Grifols Delivers First Manufactured Batches Of Its Anti-SARS-CoV-2 Hyperimmune Globulin For Clinical Trials
By PR Newswire
Jul 28, 2020 10:41 AM EDT
PRESS RELEASES
Results Of Grifols' AMBAR Clinical Trial Published In Alzheimer's & Dementia: The Journal Of The Alzheimer's Association
By PR Newswire
Jul 27, 2020 1:18 PM EDT
PRESS RELEASES
Grifols To Acquire Green Cross Plasma Fractionation Facility In Montreal And A Plasma Collection Organization In The U.S. For US$460 Million
By PR Newswire
Jul 20, 2020 2:39 AM EDT
PRESS RELEASES
Rigel Announces Availability Of TAVLESSE® (Fostamatinib Disodium Hexahydrate) In Europe
By PR Newswire
Jul 9, 2020 8:19 AM EDT
PRESS RELEASES
Grifols Starts Production Of Its Hyperimmune Immunoglobulin As A Potential Passive Immune Therapy Against COVID-19
By PR Newswire
Jun 11, 2020 4:03 AM EDT
PRESS RELEASES
Racing Against Time, Medical Researchers, Life Science Companies And COVID-19 Survivors Launch National Campaign To Drive Blood Plasma Donation
By PR Newswire
May 26, 2020 9:00 AM EDT
PRESS RELEASES
Grifols Procleix Panther System With Automation Ready Technology (ART) Receives FDA Approval
By PR Newswire
May 7, 2020 9:00 AM EDT
PRESS RELEASES
Grifols Launches New 3-mL (900-IU) Vial For High-potency HyperRAB® (rabies Immune Globulin [human])
By PR Newswire
Apr 28, 2020 9:00 AM EDT
PRESS RELEASES
Grifols 2019 Annual Report On Form 20-F Filed With The SEC On April 6, 2020
By PR Newswire
Apr 6, 2020 9:30 AM EDT
PRESS RELEASES
Grifols PharmacyKeeper Ranked No. 1 In KLAS Rating, Extends Category Leadership
By PR Newswire
Feb 13, 2020 9:00 AM EST
PERSONAL FINANCE
Stay Away From These Closed-End Funds
By Kevin Baker
Sep 18, 2008 1:30 AM EDT
MARKETS
Stay Away From These Closed-End Funds
By Kevin Baker
Sep 17, 2008 11:02 AM EDT
INVESTING
Top Closed-End Funds Sniff Out Energy Bets
By Sam Patel
Sep 15, 2008 11:50 AM EDT
